Welcome to our dedicated page for CPTA news (Ticker: CPTA), a resource for investors and traders seeking the latest updates and insights on CPTA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CPTA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CPTA's position in the market.
Capitala Group announced a successful exit from its senior secured debt and minority equity investment in Option Rx, a specialty compounding pharmacy operator in the U.S. This investment, made in partnership with Cold Bore Capital, supported Option Rx's growth through acquisitions in various healthcare sectors including fertility and veterinary services. Adam Richeson from Capitala expressed pride in the exit coinciding with Veterans Day, highlighting the partnership's focus on preserving family-owned business legacies.
Capitala Finance Corp. (CPTA) reported its third-quarter financial results for 2020, showing a 3% increase in Net Asset Value (NAV) per share to $39.99. The Company reduced its debt-to-equity ratio from 2.64 to 1.99 by repaying $59 million of SBA debentures. Total investment income decreased to $6.7 million from $10.1 million year-over-year, while net investment income fell to $0.7 million or $0.27 per share. However, net unrealized appreciation was $14.8 million per share.
Capitala Group announced an investment in Mason West, a leader in engineered seismic restraint and vibration isolation products, marking a strategic move to support ongoing market expansion. The investment comprises both debt and equity capital. Mason West, based in Southern California, serves Mechanical, Electrical, and Plumbing contractors across various sectors, including healthcare and education. Capitala collaborates with Gladstone Investment Corporation and KCM Capital Partners to enhance Mason West’s growth trajectory.
Capitala Finance Corp. (Nasdaq:CPTA) will release its third quarter 2020 financial results on November 3, 2020, after market close. A conference call to discuss these results is scheduled for November 4, 2020, at 8:30 a.m. EDT, accessible via the company’s investor relations website. Capitala Finance Corp. focuses on investing in first and second lien loans, subordinated debt, and equity securities for lower and traditional middle-market companies, managed by Capitala Investment Advisors.
Capitala Finance Corp. (CPTA) reported its second quarter 2020 results, highlighting a rise in NAV per share to $6.46 from $6.27 in Q1 2020. The company generated $51.1 million in liquidity through repayments and the wind down of Capitala Senior Loan Fund II. Total investment income was $7.0 million, down from $11.6 million in Q2 2019. The firm recorded net realized losses of $13.3 million, with net unrealized appreciation of $17.0 million. The company plans to reduce leverage and explore new investments with its $95.2 million in cash as of June 30, 2020.
Capitala Group has expanded its underwriting and investor relations teams to better support middle-market companies amidst market uncertainty. Stuart McGoogan joins as Investor Relations Associate, while Nico Mancuso and Kevin Mansfield take roles as Associate and Analyst in underwriting, respectively. The firm, which manages $3.0 billion in assets, has a 20-year history of investing in over 160 companies across North America. Their strategy focuses on partnering with management teams to optimize value and deliver strong returns for investors.
Capitala Finance Corp. reported significant portfolio activity for Q2 2020, receiving over $51.1 million in repayments. This includes $17.8 million from Flavors Holdings and $13.1 million from the wind-down of Capitala Senior Loan Fund II. As of June 30, 2020, the company holds approximately $95.2 million in cash, allowing for ongoing support to portfolio companies and debt obligations. Capitala Finance focuses on providing capital to lower middle market companies, with a history of investing in over 160 companies.
Capitala Finance Corp. (CPTA) announced it will release its Q2 2020 financial results on August 4, 2020, after market close. A conference call to discuss these results is scheduled for August 5, 2020, at 8:30 a.m. EDT. The call will be accessible via the Company's investor relations website. Capitala Finance specializes in investing in first and second lien loans and subordinated debt, focusing on lower and traditional middle market companies. The firm, part of Capitala Group, boasts over $3.0 billion in assets under management.
Capitala Finance Corp. (NASDAQ:CPTA) announced its Q1 2020 financial results, revealing a net asset value decline of $2.87 per share, largely due to a $1.18 decrease from unrealized depreciation linked to equity investments. The company suspended regular distributions for Q2 2020, citing economic impacts from COVID-19. As of March 31, 2020, its portfolio consisted of 41 companies valued at $321.2 million, with significant investments in first lien debt and notable increases in non-accrual loans, totaling $68.0 million, primarily driven by the pandemic's effects.
Capitala Finance Corp. (NASDAQ:CPTA) reported a significant impact from COVID-19, leading to a net asset value per share decline of $2.87 in Q1 2020. Approximately 41% of this drop stemmed from unrealized depreciation on equity investments. The company announced the suspension of regular distributions for Q2 2020, citing the need for better visibility into net investment income. The investment portfolio, valued at $321.2 million, includes 41 companies, with 65.7% in first lien debt. Non-accrual loans rose to $68 million due to pandemic effects.
